161 related articles for article (PubMed ID: 34836660)
1. Immunization with recombinant ORF2 p551 protein protects common marmosets (Callithrix jacchus) against homologous and heterologous hepatitis E virus challenge.
Gordeychuk I; Kyuregyan K; Kondrashova A; Bayurova E; Gulyaev S; Gulyaeva T; Potemkin I; Karlsen A; Isaeva O; Belyakova A; Lyashenko A; Sorokin A; Chumakov A; Morozov I; Isaguliants M; Ishmukhametov A; Mikhailov M
Vaccine; 2022 Jan; 40(1):89-99. PubMed ID: 34836660
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and protective efficacy in rhesus monkeys of a recombinant ORF2 protein from hepatitis E virus genotype 4.
Huang WJ; Zhang HY; Harrison TJ; Lan HY; Huang GY; Wang YC
Arch Virol; 2009; 154(3):481-8. PubMed ID: 19240977
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs.
Sanford BJ; Opriessnig T; Kenney SP; Dryman BA; Córdoba L; Meng XJ
Vaccine; 2012 Sep; 30(44):6249-55. PubMed ID: 22906724
[TBL] [Abstract][Full Text] [Related]
4. Immunization of human hepatitis E viruses conferred protection against challenge by a camel hepatitis E virus.
Guo Y; Yang F; Xu X; Feng M; Liao Y; He Z; Takeda N; Muramatsu M; Li Q; Li TC
Vaccine; 2020 Oct; 38(46):7316-7322. PubMed ID: 32980200
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome analysis in rhesus macaques infected with hepatitis E virus genotype 1/3 infections and genotype 1 re-infection.
Choi YH; Zhang X; Srinivasamoorthy G; Purdy MA
PLoS One; 2020; 15(9):e0237618. PubMed ID: 32877413
[TBL] [Abstract][Full Text] [Related]
6. Ectopic Expression of Genotype 1 Hepatitis E Virus ORF4 Increases Genotype 3 HEV Viral Replication in Cell Culture.
Yadav KK; Boley PA; Fritts Z; Kenney SP
Viruses; 2021 Jan; 13(1):. PubMed ID: 33430442
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and Antigenicity of Rabbit Hepatitis E Virus-Like Particles Produced by Recombinant Baculoviruses.
Bai H; Kataoka M; Ami Y; Suzaki Y; Takeda N; Muramatsu M; Li TC
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452436
[TBL] [Abstract][Full Text] [Related]
8. Expression and immunogenicity of hepatitis E virus-like particles based on recombinant truncated ORF2 capsid protein.
Cao YF; Zhou YF; Zhao DY; Chang JL; Tang JG; Chang DY; Zhang XM; Wang XP
Protein Expr Purif; 2023 Mar; 203():106214. PubMed ID: 36526214
[TBL] [Abstract][Full Text] [Related]
9. Prior infection of pigs with a genotype 3 swine hepatitis E virus (HEV) protects against subsequent challenges with homologous and heterologous genotypes 3 and 4 human HEV.
Sanford BJ; Dryman BA; Huang YW; Feagins AR; Leroith T; Meng XJ
Virus Res; 2011 Jul; 159(1):17-22. PubMed ID: 21536085
[TBL] [Abstract][Full Text] [Related]
10. Recombinant Hepatitis E virus like particles can function as RNA nanocarriers.
Panda SK; Kapur N; Paliwal D; Durgapal H
J Nanobiotechnology; 2015 Jun; 13():44. PubMed ID: 26104584
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and efficacy of a bacterially expressed HEV ORF3 peptide, assessed by experimental infection of primates.
Ma H; Song X; Harrison TJ; Li R; Huang G; Zhang H; Kong W; Wang Y
Arch Virol; 2009; 154(10):1641-8. PubMed ID: 19763777
[TBL] [Abstract][Full Text] [Related]
12. Management of hepatitis E virus (HEV) zoonotic transmission: protection of rabbits against HEV challenge following immunization with HEV 239 vaccine.
Liu P; Du Rj; Wang L; Han J; Liu L; Zhang Yl; Xia Jk; Lu Fm; Zhuang H
PLoS One; 2014; 9(1):e87600. PubMed ID: 24498149
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a genotype 3 recombinant protein-based immunoassay for hepatitis E virus serology in swine.
van der Poel WH; Pavio N; van der Goot J; van Es M; Martin M; Engel B
Braz J Med Biol Res; 2014 Apr; 47(4):334-9. PubMed ID: 24676472
[TBL] [Abstract][Full Text] [Related]
14. Cross-protection of hepatitis E virus genotypes 1 and 4 in rhesus macaques.
Huang W; Zhang H; Harrison TJ; Lang S; Huang G; Wang Y
J Med Virol; 2008 May; 80(5):824-32. PubMed ID: 18360896
[TBL] [Abstract][Full Text] [Related]
15. Successful passive and active immunization of cynomolgus monkeys against hepatitis E.
Tsarev SA; Tsareva TS; Emerson SU; Govindarajan S; Shapiro M; Gerin JL; Purcell RH
Proc Natl Acad Sci U S A; 1994 Oct; 91(21):10198-202. PubMed ID: 7937861
[TBL] [Abstract][Full Text] [Related]
16. Production of a Hepatitis E Vaccine Candidate Using the Pichia pastoris Expression System.
Gupta J; Kumar A; Surjit M
Methods Mol Biol; 2022; 2412():117-141. PubMed ID: 34918244
[TBL] [Abstract][Full Text] [Related]
17. Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy.
Sridhar S; Situ J; Cai JP; Yip CC; Wu S; Zhang AJ; Wen L; Chew NF; Chan WM; Poon RW; Chan JF; Tsang DN; Chen H; Xia NS; Yuen KY
J Hepatol; 2021 Jun; 74(6):1315-1324. PubMed ID: 33845058
[TBL] [Abstract][Full Text] [Related]
18. Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV).
Purdy MA; McCaustland KA; Krawczynski K; Spelbring J; Reyes GR; Bradley DW
J Med Virol; 1993 Sep; 41(1):90-4. PubMed ID: 8228944
[TBL] [Abstract][Full Text] [Related]
19. Production and characterization of a Brazilian candidate antigen for Hepatitis E Virus genotype 3 diagnosis.
de Almeida Ramos D; Miani M; Pandolfi R; Tondo L; Colli ML; Rosado Spilki F; Rovaris Gardinali N; Alves Pinto M; Kreutz LC; Frandoloso R
FEMS Microbiol Lett; 2016 Mar; 363(5):fnw021. PubMed ID: 26832642
[TBL] [Abstract][Full Text] [Related]
20. Production of capsid proteins of rat hepatitis E virus in Escherichia coli and characterization of self-assembled virus-like particles.
Kobayashi T; Takahashi M; Ohta S; Nagashima S; Primadharsini PP; Mulyanto ; Kunita S; Murata K; Okamoto H
Virus Res; 2021 Sep; 302():198483. PubMed ID: 34146611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
